The number of people with diabetes is rising worldwide. This is expected to fuel market expansion. According to the International Diabetes Federation, diabetes will affect almost 537 million adults worldwide in 2021, making it one of the most common medical conditions. By 2030, 643 million people are anticipated to be impacted, and by 2045, 783 million people. In Europe, 19.3 million people aged 60 to 79, 11.3 million people aged 40 to 59, and 1.7 million people aged 20 to 39 had diabetes in 2019.
Data Bridge Market Research analyses that the Wound Debridement Devices Market was valued at USD 470.93 million in 2021 and is expected to reach USD 728.23 million by 2029, registering a CAGR of 5.60% during the forecast period of 2022 to 2029. The market is expected to be driven by the growing prevalence of chronic illnesses such pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed nations, and changing lifestyles. Additionally, it is projected that rising rates of trauma events, burns, and other injuries due to incidents like road accidents will propel the market. In addition, the market is anticipated to benefit from the growing senior population and rising government and private sector activities to increase awareness of wound care procedures.
Increasing growth of emerging economies is expected to drive the market's growth rate
The number of surgeries and the number of chronic diseases are highly prevalent in developed countries. The wound debridement procedure is also growing in developing countries. In developing countries, minor trauma can lead to tropical ulcers, which are highly progressive and sometimes become highly malignant. In developing countries, the population is rising at a high rate, and accordingly, the elderly population is also rising. New research and development are also progressing in wound debridement, creating opportunities for big companies in developing countries.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Hydrosurgical, Low-Frequency Ultrasound, Mechanical, Larval Therapy, Others), Method (Autolytic, Surgical, Enzymatic, Mechanical, Maggot), Wound Type (Surgical Wounds, Diabetic Ulcers, Burns, Pressure Ulcers, Venous Ulcers, Others), End User (Hospitals, Wound Care Centre, Ambulatory Centre, Home Healthcare, Clinics, Community Healthcare)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Smith+Nephew (U.K.), Medtronic (Ireland), Zimmer Biomet (U.S.), Integra LifeSciences (U.S.), Abbott (U.S.), B. Braun Melsungen AG (Germany), Mölnlycke Health Care AB (Sweden), Coloplast Group (Denmark), Organogenesis Inc. (U.S.), Misonix, Inc. (U.S.), Hollister Incorporated (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), Arobella Medical (U.S.), BSN Medical (Hamburg), Advanced Medical Solutions Group plc (U.K.), Advancis Medical (U.K.), BioMonde (U.K.), DeRoyal Industries, Inc. (U.S.), Italia Medica SRL (Italy), Söring GmbH (Germany), Olympus Corporation (Japan) among others
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global wound debridement devices market is categorized into four notable segments which are based on the product, method, wound type and end user.
- On the basis of product, global wound debridement devices market is segmented into hydrosurgical, low-frequency ultrasound, mechanical, larval therapy and others. In 2021, hydrosurgical segment dominated the market with 58.9% market share because of the growing geriatric population.
- On the basis of method, global wound debridement devices market is segmented into autolytic, enzymatic, surgical, mechanical and maggot. In 2021, autolytic segment dominated the market with 53.58% market share owing to the increasing diabetes and related wounds.
- On the basis of wound type, global wound debridement devices market is segmented into surgical wounds, diabetic ulcers, burns, pressure ulcers, venous ulcers and others. In 2021, surgical wounds segment dominated the market with 41.62% market share because of growing number of surgeries.
Surgical wounds dominates the wound type segment of the wound debridement devices market
In 2021, hospitals segment emerged as the dominating segment with 41% market share. This is because of the cost of healthcare, healthcare service providers are focusing on better services for customers along with reducing the overall cost. Growing awareness about the benefits of surgical procedures will further bolster the growth of the market. Also, growth and expansion of the healthcare industry and increasing personal disposable income will yet again bolster the growth and dominance of this segment.
- On the basis of end user, global wound debridement devices market is segmented into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and community healthcare. In 2021, hospitals segment dominated the market with 42.14% market share due to the rising number of hospitals across the globe.
Hospitals dominates the end user segment of the wound debridement devices market
In 2021, hospitals segment emerged as the dominating segment with 42% market share. This is because of the cost of healthcare, healthcare service providers are focusing on better services for customers along with reducing the overall cost. Also, software and services are provided on a big level in companies and other organizations that require a cost effective scheme, which will bolster this segment's growth and dominance.
Major Players
Data Bridge Market Research recognizes the following companies as the major market players: Smith+Nephew (U.K.), Medtronic (Ireland), Zimmer Biomet (U.S.), Integra LifeSciences (U.S.), Abbott (U.S.), B. Braun Melsungen AG (Germany), Mölnlycke Health Care AB (Sweden), Coloplast Group (Denmark), Organogenesis Inc. (U.S.), Misonix, Inc. (U.S.), Hollister Incorporated (U.S.), (Italy), Söring GmbH (Germany), and Olympus Corporation (Japan).
Market Development
- A centralized platform for clinicians to access timely news, specialised content from the organization's best-in-class wound care journals, expert insight, clinical research highlights, and educational tools was introduced by HMP Global in June 2022 with the launch of the Wound Care Learning Network.
- Essity Aktiebolag, a Swedish corporation, bought Hydrofera, an American business, in December 2021. Hydrofera provides technology and goods for improved wound treatment. The objective behind this acquisition was to expand Essity ' 'Aktiebolag's territorial hold and emerge as a competitive player in the global wound debridement devices market.
Regional Analysis
Geographically, the countries covered in the wound debridement devices market report are U.S., Canada and Mexico in U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
As per Data Bridge Market Research analysis:
North America is the dominant region in wound debridement devices market during the forecast period 2022 to 2029
In 2021, North America is dominating in the wound debridement devices market due to the presence of major market players and increased technological advancement in the region. U.S. is dominating in North American market due to the existence of advanced healthcare technologies and rise in use of medical devices.
Asia-Pacific is estimated to be the fastest-growing region in wound debridement devices market the forecast period 2022 to 2029
Asia-Pacific is expected to grow during the forecast period due to the surging incidence rate of chronic and acute disorders, rising medical tourism in the region, and rapid development of infrastructural facilities in emerging economies such as India and China.
COVID-19 Impact Analysis
The COVID-19 pandemic had a negative impact on people all around the world, but it was particularly severe in undeveloped and underdeveloped nations. It forced the cancellation of numerous medical treatments, including operations that had an influence on the wound debridement market. For instance, the British Journal of Surgery reported that in May 2020, approximately 48,728 surgical procedures each week—or over 585,000 surgical procedures over 12 weeks-were canceled in India. However, the wound debridement market is likely to move back toward growth due to a decline in COVID-19 infections and a widespread immunization campaign around the world. The market under study is also anticipated to reclaim its potential within the study's forecast period.
For more detailed information about the wound debridement devices market report, click here – https://www.databridgemarketresearch.com/reports/global-wound-debridement-devices-market
